fig2

Figure 2. PhenoAge acceleration on cirrhosis in different subgroups among the MASLD population. HRs and 95%CIs were estimated with adjustment for age, sex, ethnicity, Townsend deprivation index, body mass index, alcohol status, smoking status, physical activity, history of hypertension, history of diabetes, and history of heart disease. MASLD: Metabolic dysfunction-associated steatotic liver disease; BMI: body mass index; HR: hazard ratio; 95%CI: 95% confidence interval.